ARCHIVES

NMP22 Assay More Effective Than Conventional Lab Test

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008

Oncology Management: US Oncology To Conduct Up To 5 Studies Of PG-TXL In Colorectal, Lung Cancers

June 1, 2001

Next issue of The Cancer Letter is scheduled for Jan. 7, 2005.

December 10, 2004

Obituary: Carl Baker, Former NCI Director

March 13, 2009

FDA Approves Implant For Breast Reconstruction

July 26, 2013

In Brief: GAO Reopens Clinical Center Controversy On Patient Care Payment; NIH Still Resists

January 6, 1978